Pharma & Biotech

The biotechnology sector is witnessing notable momentum in Cellectar Biosciences, with the company's stock demonstrating substantial upward movement following significant...

CureVac investors have officially cleared the path for the company's acquisition by vaccine developer BioNTech, bringing months of anticipation to...

Recent activity at Cassava Sciences reveals a compelling narrative of executive confidence and strategic financial positioning. The biotechnology firm's leadership...

Pfizer is making significant strides in reshaping its post-pandemic trajectory, with recent clinical trial results generating substantial excitement among investors....

Shares of Hims & Hers Health experienced a significant rally, climbing nearly 9% following the company's announcement of a major...

A curious divergence defines the current situation for Bionxt Solutions. The company continues to hit significant operational targets, yet its...

The investment case for Eli Lilly continues to strengthen, even after the pharmaceutical giant surpassed a $1 trillion market valuation....

Eli Lilly has cemented its leadership in the pharmaceutical industry by becoming the first company in the sector to surpass...

While Healwell AI has reported staggering financial growth, its stock performance tells a contradictory and alarming story. The company's latest...

AngioDynamics is demonstrating remarkable market momentum, driven by impressive quarterly results, favorable analyst coverage, and a significant regulatory development concerning...